Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Corteva, Inc. (NYSE:CTVA – Free Report) by 58.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,239 shares of the company’s stock after buying an additional 15,527 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Corteva were worth $3,536,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. JPL Wealth Management LLC purchased a new stake in Corteva during the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva during the 4th quarter valued at approximately $27,000. Bank of Jackson Hole Trust bought a new position in shares of Corteva during the 4th quarter valued at approximately $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva during the 4th quarter valued at $29,000. Finally, Basepoint Wealth LLC bought a new stake in Corteva in the fourth quarter worth $30,000. Institutional investors own 81.54% of the company’s stock.
Corteva Price Performance
Corteva stock opened at $89.39 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock has a market cap of $59.79 billion, a price-to-earnings ratio of 52.58, a price-to-earnings-growth ratio of 2.74 and a beta of 0.56. The firm has a 50-day moving average of $82.16 and a two-hundred day moving average of $79.55. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97.
Corteva Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.
More Corteva News
Here are the key news stories impacting Corteva this week:
- Positive Sentiment: Quarterly earnings exceeded expectations: Corteva reported second-quarter EPS of $2.30, above the $2.24 consensus estimate and up from $2.20 a year earlier. Corteva Q2 Earnings Beat Estimates
- Positive Sentiment: Full-year outlook was raised: Management increased its 2026 EPS guidance to $3.60-$3.80, reflecting strong first-half performance, cost controls and growth from strategic platforms. The midpoint is broadly consistent with analyst expectations. Corteva Delivers Strong First Half and Raises Outlook
- Positive Sentiment: Growth initiatives remain supportive: Demand for newer seed germplasm, trait technologies and crop-protection products, along with licensing growth and operational improvements, helped offset competitive pricing pressure. Corteva also remains on schedule for the planned October 1 Vylor spin-off. Why Corteva’s Seed and Crop Protection Engines Matter
- Neutral Sentiment: Separation could reshape the investment story: Corteva’s innovation pipeline, including crop-protection products and royalty opportunities, may support future growth after the planned business split, although the benefits will depend on execution. Corteva’s Innovation Pipeline
- Negative Sentiment: Revenue missed expectations: Second-quarter revenue was $6.38 billion, below the $6.60 billion analyst estimate, and declined 1.2% year over year. Competitive pricing remains a concern. Corteva Earnings Press Release
- Negative Sentiment: Valuation and execution risks are elevated: After a powerful rally, CTVA trades near its 52-week high at a premium earnings multiple. Investors may remain cautious about separation costs, execution risk and whether growth can justify the valuation. Is CTVA Stock Worth Buying After Its Rally?
Analyst Upgrades and Downgrades
Several research analysts have commented on CTVA shares. Wells Fargo & Company lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 21st. Royal Bank Of Canada raised their target price on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. UBS Group cut their price target on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. Rothschild & Co Redburn increased their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Finally, Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.19.
View Our Latest Analysis on Corteva
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
